Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.
In: Bone marrow transplantation, Jg. 42 (2008-08-01), Heft 4, S. 227-40
Online
academicJournal
Zugriff:
These recommendations were prepared by the European Conference on Infections in Leukaemia following a predefined methodology. Literature searches were made to identify studies pertinent to management of CMV, HHV-6, -7 and -8 infections. For CMV, 76 studies were reviewed: 72 published and 4 presented as abstracts. Twenty-nine of these studies were prospective randomized trials. For the other herpesviruses, HHV-6, -7 and -8, no randomized controlled trial has been performed, although data from some studies with other primary endpoints have been used to assess the management of HHV-6 infection. Works presented only as abstracts were used to a very limited extent. The quality of evidence and level of recommendation were graded according to the Center for Disease Control (CDC) criteria.
Titel: |
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT.
|
---|---|
Autor/in / Beteiligte Person: | Ljungman, P ; de la Camara R ; Cordonnier, C ; Einsele, H ; Engelhard, D ; Reusser, P ; Styczynski, J ; Ward, K |
Link: | |
Zeitschrift: | Bone marrow transplantation, Jg. 42 (2008-08-01), Heft 4, S. 227-40 |
Veröffentlichung: | <2003->: London : Nature Publishing Group ; <i>Original Publication</i>: Basingstoke, Hampshire : Scientific & Medical Division, Macmillan Press, c1986-, 2008 |
Medientyp: | academicJournal |
ISSN: | 0268-3369 (print) |
DOI: | 10.1038/bmt.2008.162 |
Schlagwort: |
|
Sonstiges: |
|